Neuroendocrine tumours and genetic disorders
Although Siegfried Oberndorfer is rightly credited with introducing the term karzinoide (carcinoma-like) in 1907, T. Langhans had in 1867 described a submucosal tumour that resembled poorly differentiated glandular tissue arranged in ‘nests’ with a rich, thick fibrous stroma (1). Thereafter in 1888, O. Lubarsch reported the post mortem identification of multiple ileal tumours, which he was reluctant to classify as ‘carcinomas’ due to a benign growth pattern appearance (2). In 1890, W.B. Ransom reported similar tumours at autopsy in the region of the ileocoecal valve with associated extensive hepatic tumours, but, in addition, emphasized the associated clinical symptoms, which included diarrhoea and wheezing (3). Nevertheless, despite these early descriptions, it remained for Oberndorfer to published his seminal paper Carcinoid Tumours of the Small Intestine in 1907 and recognize their unique nature; finally defining the lesions as a neoplasm distinct from carcinoma (Fig. 6.1.1) (4).
Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.